Trials / Completed
CompletedNCT01371019
Proteomic Assessment of Preterm Birth
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,500 (actual)
- Sponsor
- Sera Prognostics, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.
Conditions
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2014-12-01
- Completion
- 2015-04-01
- First posted
- 2011-06-10
- Last updated
- 2015-06-11
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01371019. Inclusion in this directory is not an endorsement.